Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BCY6033
i
Other names:
BCY6033
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Bicycle Therap
Drug class:
Microtubule inhibitor, EphA2 receptor antagonist
Related drugs:
‹
ado-trastuzumab emtansine (86)
eribulin mesylate (38)
brentuximab vedotin (27)
disitamab vedotin (18)
mirvetuximab soravtansine-gynx (16)
cabazitaxel (12)
ABBV-399 (10)
enfortumab vedotin (9)
ARX788 (9)
SAR408701 (7)
ixabepilone (6)
IMGC936 (4)
MRG003 (4)
BAY1129980 (4)
CBP-1008 (3)
MRG002 (3)
SGN-B7H4V (3)
ABT-414 (3)
STRO-002 (3)
ASG 5ME (2)
BB-1705 (2)
belantamab mafodotin (2)
SGN-CD228A (2)
STRO-001 (2)
XMT-1592 (2)
BAY 94-9343 (2)
E7389-LF (2)
PM184 (2)
IKS014 (2)
XMT-1536 (2)
ALT-P7 (1)
AbGn-107 (1)
BAT8001 (1)
BAT8003 (1)
BB-1701 (1)
BVX130-mcMMAF (1)
CDX-014 (1)
IMGN151 (1)
LR004-VC-MMAE (1)
MEDI4276 (1)
OBI-998 (1)
SGN-PDL1V (1)
STI-6129 (1)
tisotumab vedotin-tftv (1)
(1)
MORAb-202 (1)
CX-2009 (1)
RG7450 (1)
dasatinib (214)
ALW-II-41-27 (2)
ado-trastuzumab emtansine (86)
eribulin mesylate (38)
brentuximab vedotin (27)
disitamab vedotin (18)
mirvetuximab soravtansine-gynx (16)
cabazitaxel (12)
ABBV-399 (10)
enfortumab vedotin (9)
ARX788 (9)
SAR408701 (7)
ixabepilone (6)
IMGC936 (4)
MRG003 (4)
BAY1129980 (4)
CBP-1008 (3)
MRG002 (3)
SGN-B7H4V (3)
ABT-414 (3)
STRO-002 (3)
ASG 5ME (2)
BB-1705 (2)
belantamab mafodotin (2)
SGN-CD228A (2)
STRO-001 (2)
XMT-1592 (2)
BAY 94-9343 (2)
E7389-LF (2)
PM184 (2)
IKS014 (2)
XMT-1536 (2)
ALT-P7 (1)
AbGn-107 (1)
BAT8001 (1)
BAT8003 (1)
BB-1701 (1)
BVX130-mcMMAF (1)
CDX-014 (1)
IMGN151 (1)
LR004-VC-MMAE (1)
MEDI4276 (1)
OBI-998 (1)
SGN-PDL1V (1)
STI-6129 (1)
tisotumab vedotin-tftv (1)
(1)
MORAb-202 (1)
CX-2009 (1)
RG7450 (1)
dasatinib (214)
ALW-II-41-27 (2)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
EPHA2 expression + EGFR mutation
Non Small Cell Lung Cancer
EPHA2 expression + EGFR mutation
Non Small Cell Lung Cancer
BCY6033
Sensitive: D – Preclinical
BCY6033
Sensitive
:
D
BCY6033
Sensitive: D – Preclinical
BCY6033
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login